Twist Bioscience Corp

0ME

Company Profile

  • Business description

    Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

  • Contact

    681 Gateway Boulevard
    South San FranciscoCA94080
    USA

    T: +1 800 719-0671

    https://www.twistbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 September 2026

    Employees

    979

Stocks News & Analysis

stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.
stocks

Undervalued ASX miner hits production homerun

Record volumes, lower costs and reduced debt underpin a stronger earnings outlook for ASX miner.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.0070.20-0.76%
CAC 408,509.6424.000.28%
DAX 4025,629.2417.210.07%
Dow JONES (US)52,485.03276.970.53%
FTSE 10010,868.0529.22-0.27%
HKSE25,884.4325.550.10%
NASDAQ25,373.85251.681.00%
Nikkei 22564,362.022,494.594.03%
NZX 50 Index13,699.2863.50-0.46%
S&P 5007,489.7252.090.70%
S&P/ASX 2008,976.8073.10-0.81%
SSE Composite Index3,832.2627.570.72%

Market Movers